David Byram
Consejero General en BRAEBURN INC. .
Cargos activos de David Byram
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BRAEBURN INC. | Consejero General | - | - |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Consejero General | - | - |
Historial de carrera de David Byram
Antiguos cargos conocidos de David Byram.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OREXO AB | Corporate Officer/Principal | - | - |
| STAGEZERO LIFE SCIENCES LTD. | Corporate Officer/Principal | 12/07/2018 | - |
Formación de David Byram.
| Indiana University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
| Suecia | 2 |
Operativa
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| OREXO AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Bolsa de valores
- Insiders
- David Byram
- Experiencia
